European Pharmaceutical Review

FEBRUARY 27, 2024

The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine, will step down in the Autumn following five years in the role. Previous roles The MHRA highlighted Dame June Raine has been Chief Executive Officer of the MHRA since August 2019.

Safety 111

Safety Pharmacology Medicine Education 111

Clarivate

SEPTEMBER 11, 2024

Personalized care relies on pharmacological and non-pharmacological interventions aimed at (temporarily) relieving cognitive and non-cognitive symptoms (Alzheimer’s Association, n.d.; Creative Art Therapy as a Non-Pharmacological Intervention for Dementia: A Systematic Review. 2024; Quanterix, 2024). Emblad, S. Esquivel, R.

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59

MedCity News

JUNE 16, 2023

The evolution to the new normal Given the evolving climate, Rock Health provided the apt advice as: “rather than aiming to ‘disrupt’ the entire healthcare system, focus is best placed on applying practiced skill sets to top healthcare and research problems.”

Pharma 110

Pharma Food and Drug Administration Recruitment Patients 110

Medgadget

MAY 2, 2023

While for other patients the possible adverse side effects from medication may prevent them from finding pharmacological therapies effective. Throughout 2016 and until mid-2019 we conducted a deep technology due diligence, as well as market research, and met and spoke with dozens of mental healthcare providers.

Side effects 86

Side effects Prescription Healthcare Healthcare 86

Pharmaceutical Technology

NOVEMBER 3, 2022

Cardiovascular medicines were ranked as the sixth most affected drug class by shortages, as per a 2019 European Association of Hospital Pharmacists (EAHP) survey, says the organisation’s director of finance, Nenad Miljkovi?. To me, even [if] a shortage has resolved, it is only a matter of time until it happens again,” he explains.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111

European Pharmaceutical Review

MAY 2, 2023

In 2019, the pharmaceutical industry spent $83 billion on R&D, which is about 10 times what the industry spent per year in the 1980s, 4 yet the average duration to develop a new medicine is still around 10-15 years. About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe.

Patients 105

Patients Medicine Marketing Medical 105

European Pharmaceutical Review

MARCH 11, 2024

About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019. With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety.

Medicine 98

Medicine Pharmacology Healthcare Healthcare 98